Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Felezonexor by Stemline Therapeutics for Breast Cancer: Likelihood of Approval
Felezonexor is under clinical development by Stemline Therapeutics and currently in Phase I for Breast Cancer. According to GlobalData, Phase...
Felezonexor by Stemline Therapeutics for Colorectal Cancer: Likelihood of Approval
Felezonexor is under clinical development by Stemline Therapeutics and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...
Felezonexor by Stemline Therapeutics for Solid Tumor: Likelihood of Approval
Felezonexor is under clinical development by Stemline Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
Felezonexor by Stemline Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
Felezonexor is under clinical development by Stemline Therapeutics and currently in Phase I for Non-Small Cell Lung Cancer. According to...
Felezonexor by Stemline Therapeutics for Urinary Tract Cancer: Likelihood of Approval
Felezonexor is under clinical development by Stemline Therapeutics and currently in Phase I for Urinary Tract Cancer. According to GlobalData,...
Felezonexor by Stemline Therapeutics for Neuroendocrine Tumors: Likelihood of Approval
Felezonexor is under clinical development by Stemline Therapeutics and currently in Phase I for Neuroendocrine Tumors. According to GlobalData, Phase...
Felezonexor by Stemline Therapeutics for Gastrointestinal Tumor: Likelihood of Approval
Felezonexor is under clinical development by Stemline Therapeutics and currently in Phase I for Gastrointestinal Tumor. According to GlobalData, Phase...